GoHealth, Inc. (GOCO) intrinsic value & 10-year financials
GoHealth, Inc. (GOCO) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 9 fiscal years revenue grew 6.9% a year to $361.8M, with an average return on invested capital of -29.7%.
- Graham intrinsic value
- —
- Revenue (FY2025)
- $361.8M
- Revenue growth (9-yr CAGR)
- 6.9%
- ROIC (10-yr avg)
- -29.7%
- Free cash flow (FY2025)
- -$130.2M
GOCO 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $361.8M | -$257.1M | -$20.17 | -$130.2M | -114.1% | -58.5% |
| FY2024 | $798.9M | -$2.9M | -$0.66 | -$35.3M | -0.9% | -1.0% |
| FY2023 | $734.7M | -$63.3M | -$7.19 | $95.4M | -11.1% | -11.1% |
| FY2022 | $631.7M | -$148.7M | -$17.72 | $47.4M | -50.4% | -36.2% |
| FY2021 | $1.1B | -$189.4M | -$1.79 | -$318.8M | -46.1% | -61.3% |
| FY2020 | $877.4M | -$44.3M | -$0.22 | -$128.7M | -7.4% | -10.1% |
| FY2019 | $0 | — | — | — | — | — |
| FY2018 | $226.2M | $28.1M | — | -$727.0K | 12.7% | — |
| FY2017 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GoHealth, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
GoHealth, Inc. has historically struggled to out-earn its cost of capital, averaging just -29.7% ROIC.
GoHealth, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, GoHealth, Inc. is modeled at 6.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-389.45 per share.